Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies
Authors
Keywords
Trientine, Carboplatin, Platinum resistance, Copper, Ceruloplasmin
Journal
INVESTIGATIONAL NEW DRUGS
Volume 32, Issue 3, Pages 465-472
Publisher
Springer Nature
Online
2013-12-04
DOI
10.1007/s10637-013-0051-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of the Human High-Affinity Copper Transporter in Copper Homeostasis Regulation and Cisplatin Sensitivity in Cancer Chemotherapy
- (2012) M. T. Kuo et al. CANCER RESEARCH
- Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent
- (2012) Siqing Fu et al. MOLECULAR CANCER THERAPEUTICS
- Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents
- (2012) Z. D. Liang et al. MOLECULAR CANCER THERAPEUTICS
- Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy
- (2011) Helen H.W. Chen et al. LUNG CANCER
- Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer
- (2010) Siqing Fu et al. CANCER
- Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
- (2010) Seiko Ishida et al. CANCER CELL
- Overcoming platinum resistance in ovarian carcinoma
- (2010) Koji Matsuo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Triethylenetetramine Pharmacology and Its Clinical Applications
- (2010) J. Lu MOLECULAR CANCER THERAPEUTICS
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
- (2010) S. B. Howell et al. MOLECULAR PHARMACOLOGY
- Novel strategies for reversing platinum resistance
- (2009) Mian M.K. Shahzad et al. DRUG RESISTANCE UPDATES
- Mechanistic Comparison of Human High-Affinity Copper Transporter 1-Mediated Transport between Copper Ion and Cisplatin
- (2009) Z. D. Liang et al. MOLECULAR PHARMACOLOGY
- Treatment of Wilson's disease with tetrathiomolybdate: V. control of free copper by tetrathiomolybdate and a comparison with trientine
- (2009) George J. Brewer et al. Translational Research
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancer
- (2008) Franco Muggia GYNECOLOGIC ONCOLOGY
- A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer
- (2008) Elaina M. Gartner et al. INVESTIGATIONAL NEW DRUGS
- Elevated Glutathione Levels Confer Cellular Sensitization to Cisplatin Toxicity by Up-Regulation of Copper Transporter hCtr1
- (2008) H. H. W. Chen et al. MOLECULAR PHARMACOLOGY
- Mechanisms for copper acquisition, distribution and regulation
- (2008) Byung-Eun Kim et al. Nature Chemical Biology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now